197 related articles for article (PubMed ID: 24825455)
1. Ablation of osteopontin improves the skeletal phenotype of phospho1(-/-) mice.
Yadav MC; Huesa C; Narisawa S; Hoylaerts MF; Moreau A; Farquharson C; Millán JL
J Bone Miner Res; 2014 Nov; 29(11):2369-81. PubMed ID: 24825455
[TBL] [Abstract][Full Text] [Related]
2. Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification.
Yadav MC; Simão AM; Narisawa S; Huesa C; McKee MD; Farquharson C; Millán JL
J Bone Miner Res; 2011 Feb; 26(2):286-97. PubMed ID: 20684022
[TBL] [Abstract][Full Text] [Related]
3. In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin.
Narisawa S; Yadav MC; Millán JL
J Bone Miner Res; 2013 Jul; 28(7):1587-98. PubMed ID: 23427088
[TBL] [Abstract][Full Text] [Related]
4. Skeletal Mineralization Deficits and Impaired Biogenesis and Function of Chondrocyte-Derived Matrix Vesicles in Phospho1(-/-) and Phospho1/Pi t1 Double-Knockout Mice.
Yadav MC; Bottini M; Cory E; Bhattacharya K; Kuss P; Narisawa S; Sah RL; Beck L; Fadeel B; Farquharson C; Millán JL
J Bone Miner Res; 2016 Jun; 31(6):1275-86. PubMed ID: 26773408
[TBL] [Abstract][Full Text] [Related]
5. The role of phosphatases in the initiation of skeletal mineralization.
Millán JL
Calcif Tissue Int; 2013 Oct; 93(4):299-306. PubMed ID: 23183786
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick.
Macrae VE; Davey MG; McTeir L; Narisawa S; Yadav MC; Millan JL; Farquharson C
Bone; 2010 Apr; 46(4):1146-55. PubMed ID: 20053388
[TBL] [Abstract][Full Text] [Related]
7. Compounded PHOSPHO1/ALPL deficiencies reduce dentin mineralization.
McKee MD; Yadav MC; Foster BL; Somerman MJ; Farquharson C; Millán JL
J Dent Res; 2013 Aug; 92(8):721-7. PubMed ID: 23694930
[TBL] [Abstract][Full Text] [Related]
8. Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice.
Harmey D; Johnson KA; Zelken J; Camacho NP; Hoylaerts MF; Noda M; Terkeltaub R; Millán JL
J Bone Miner Res; 2006 Sep; 21(9):1377-86. PubMed ID: 16939396
[TBL] [Abstract][Full Text] [Related]
9. Role of PHOSPHO1 in Periodontal Development and Function.
Zweifler LE; Ao M; Yadav M; Kuss P; Narisawa S; Kolli TN; Wimer HF; Farquharson C; Somerman MJ; Millán JL; Foster BL
J Dent Res; 2016 Jul; 95(7):742-51. PubMed ID: 27016531
[TBL] [Abstract][Full Text] [Related]
10. Tooth root dentin mineralization defects in a mouse model of hypophosphatasia.
Foster BL; Nagatomo KJ; Tso HW; Tran AB; Nociti FH; Narisawa S; Yadav MC; McKee MD; Millán JI; Somerman MJ
J Bone Miner Res; 2013 Feb; 28(2):271-82. PubMed ID: 22991301
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy Using Recombinant AAV Type 8 Vector Encoding TNAP-D
Amadeu de Oliveira F; Mohamed FF; Kinoshita Y; Narisawa S; Farquharson C; Miyake K; Foster BL; Millan JL
JBMR Plus; 2023 Jan; 7(1):e10709. PubMed ID: 36699639
[TBL] [Abstract][Full Text] [Related]
12. Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.
Ao M; Chavez MB; Chu EY; Hemstreet KC; Yin Y; Yadav MC; Millán JL; Fisher LW; Goldberg HA; Somerman MJ; Foster BL
Bone; 2017 Dec; 105():134-147. PubMed ID: 28866368
[TBL] [Abstract][Full Text] [Related]
13. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.
Gasque KC; Foster BL; Kuss P; Yadav MC; Liu J; Kiffer-Moreira T; van Elsas A; Hatch N; Somerman MJ; Millán JL
Bone; 2015 Mar; 72():137-47. PubMed ID: 25433339
[TBL] [Abstract][Full Text] [Related]
14. Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia.
Hoac B; Østergaard M; Wittig NK; Boukpessi T; Buss DJ; Chaussain C; Birkedal H; Murshed M; McKee MD
J Bone Miner Res; 2020 Oct; 35(10):2032-2048. PubMed ID: 32501585
[TBL] [Abstract][Full Text] [Related]
15. Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice.
Mohamed FF; Hoac B; Phanrungsuwan A; Tan MH; Giovani PA; Ghiba S; Murshed M; Foster BL; McKee MD
Bone; 2023 Nov; 176():116886. PubMed ID: 37634682
[TBL] [Abstract][Full Text] [Related]
16. Phospho1 deficiency transiently modifies bone architecture yet produces consistent modification in osteocyte differentiation and vascular porosity with ageing.
Javaheri B; Carriero A; Staines KA; Chang YM; Houston DA; Oldknow KJ; Millan JL; Kazeruni BN; Salmon P; Shefelbine S; Farquharson C; Pitsillides AA
Bone; 2015 Dec; 81():277-291. PubMed ID: 26232374
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-D
Kinoshita Y; Mohamed FF; Amadeu de Oliveira F; Narisawa S; Miyake K; Foster BL; Millán JL
J Bone Miner Res; 2021 Sep; 36(9):1835-1849. PubMed ID: 34076297
[TBL] [Abstract][Full Text] [Related]
18. Perspective on Dentoalveolar Manifestations Resulting From PHOSPHO1 Loss-of-Function: A Form of Pseudohypophosphatasia?
Mohamed FF; Chavez MB; de Oliveira FA; Narisawa S; Farquharson C; Millán JL; Foster BL
Front Dent Med; 2022 Feb; 3():. PubMed ID: 36185572
[TBL] [Abstract][Full Text] [Related]
19. Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization.
Roberts S; Narisawa S; Harmey D; Millán JL; Farquharson C
J Bone Miner Res; 2007 Apr; 22(4):617-27. PubMed ID: 17227223
[TBL] [Abstract][Full Text] [Related]
20. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.
Harmey D; Hessle L; Narisawa S; Johnson KA; Terkeltaub R; Millán JL
Am J Pathol; 2004 Apr; 164(4):1199-209. PubMed ID: 15039209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
